New hope for seniors with rare blood cancer: drug combo trial launches
Disease control
Recruiting now
This study tests whether alternating two different drug combinations works better than the standard treatment for older adults (70+ or 60-69 if not eligible for transplant) with newly diagnosed mantle cell lymphoma. About 90 participants will receive either the standard two-drug …
Phase: PHASE2 • Sponsor: Kim, Seok Jin • Aim: Disease control
Last updated May 10, 2026 12:03 UTC